untitled design

Coreper examines case of woman death in Belgium after she was vaccinated with Johnson & Johnson

The first report of death after administration Johnson & Johnson vaccine examined by the European Medicines Agency, as well as the Belgian and Slovenian drug services, together with other reports of blood clots.

Answering a question from AMPE, The European Medicines Agency (EMA) said it was “aware of media reports for a blood clot with fatal outcome in a 37 year old woman in Belgium after the vaccination with the Janssen vaccine for COVID19 “and refers to an article entitled:” The wife of a Slovenian diplomat died after the vaccination and investigations have begun “.

“The woman suffered from a blood clot with low platelets (also known as thrombosis with syndrome thrombocytopenia, TTS) and the EMA, the Belgian and Slovenian drug services are examining this first report of death together with other reports of blood clot events, as part of regular intensified monitoring activity. “

It also states, according to AMPE, that “in order to assess the impact of a possible link between vaccination and TTS, the EMA asked the marketing authorization holder of the Janssen vaccine for COVID-19 to conduct a series of additional studies”.

He adds that “as of 20 May 2021, 1,346,034 doses of Janssen vaccine had been administered for COVID-19 within the EU “.

“The EMA and national authorities will continue to monitor the safety and efficacy of the vaccine and provide further updates as required. “The EMA and the national authorities are committed to ensuring that the vaccine is used as safely as possible,” the European Medicines Agency concludes.

Following the woman’s death, Belgium decided to temporarily suspend the vaccine for citizens under 41 years of age.

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular